- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00875940
Right Ventricular Hypertrophy and Pulmonary Hypertension: A Correlation Analysis
April 3, 2009 updated by: University of Cincinnati
Right Ventricular Hypertrophy and Pulmonary Hypertension: A Correlation Analysis Between Tc-99m Tetrofosmin SPECT Adn Echocardiography
The study hypothesis is that a quantitative index can be derived from Tc-99m myocardial perfusion scans that accurately identifies the presence of left ventricular hypertrophy and pulmonary hypertension.
Echocardiography provides the reference standard.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ohio
-
Cincinnati, Ohio, United States, 45267
- University of Cincinnati
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Hospital population having diagnostic testing.
Description
Inclusion Criteria:
- Must have an interpretable Tc-99m myocardial perfusion scan and an interpretable echocardiogram.
Exclusion Criteria:
- Technically inadequate noninvasive test.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Group 1
Patients having both Tc-99m perfusion scan and echocardiogram.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Sensitivity and specificity of quantitation of Tc-99m perfusion scans for identification of pulmonary hypertension.
Time Frame: 2 years
|
2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2008
Primary Completion (Actual)
January 1, 2009
Study Registration Dates
First Submitted
April 3, 2009
First Submitted That Met QC Criteria
April 3, 2009
First Posted (Estimate)
April 6, 2009
Study Record Updates
Last Update Posted (Estimate)
April 6, 2009
Last Update Submitted That Met QC Criteria
April 3, 2009
Last Verified
April 1, 2009
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB # 08-01-24-02
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pulmonary Hypertension
-
Centre Chirurgical Marie LannelongueUnknownChronic Thrombo-embolic Pulmonary Hypertension and Pulmonary Arterial HypertensionFrance
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of SheffieldCompletedIdiopathic Pulmonary Arterial Hypertension | Chronic Thromboembolic Pulmonary HypertensionUnited Kingdom
-
Heidelberg UniversityMerck Sharp & Dohme LLCRecruitingChronic Thromboembolic Pulmonary Hypertension | Primary Pulmonary Arterial HypertensionGermany
-
University of South FloridaWithdrawnPulmonary Arterial Hypertension | Familial Primary Pulmonary Hypertension | Idiopathic Pulmonary Arterial Hypertension | Primary Pulmonary HypertensionUnited States
-
BayerCompletedPrimary HypertensionChina
-
University of Kansas Medical CenterRecruitingPulmonary Arterial Hypertension | Pulmonary Hypertension | Chronic Thromboembolic Pulmonary Hypertension | Pulmonary Hypertension Due to Left Heart Disease | Pulmonary Hypertension, Primary, 4 | Pulmonary Hypertension, Primary, 2 | Pulmonary Hypertension, Primary, 3 | Pulmonary Hypertension, Primary and other conditionsUnited States
-
Vanderbilt University Medical CenterJohns Hopkins UniversityCompletedPulmonary Arterial Hypertension | Idiopathic Pulmonary Arterial Hypertension | Associated Pulmonary Arterial Hypertension | Heritable Pulmonary Arterial HypertensionUnited States
-
Papworth Hospital NHS Foundation TrustMerck Sharp & Dohme LLCCompleted
-
University of ZurichCompletedPulmonary Hypertension | Pulmonary Artery Hypertension | Chronic Thromboembolic Pulmonary HypertensionSwitzerland
-
National Taiwan University HospitalUnknownPulmonary HypertensionTaiwan
Clinical Trials on Diagnostic imaging procedures.
-
Ohio State University Comprehensive Cancer CenterNot yet recruitingLymphedema of the Head and NeckUnited States
-
University of MagdeburgUniversity of ZurichCompletedSepsis | Death | Peritonitis | Multiple Organ FailureGermany
-
Cardiovascular Associates of the Delaware ValleyAccessClosure, Inc.Completed
-
University of California, San FranciscoNational Cancer Institute (NCI); US-Latin American-Caribbean HIV/HPV-Cancer...RecruitingHIV Infection | High Grade Cervical Intraepithelial Neoplasia | AIDS-Related Anal Carcinoma | AIDS-Related Cervical Carcinoma | High Grade Anal Intraepithelial NeoplasiaPuerto Rico, Mexico
-
Mario Negri Institute for Pharmacological ResearchPapa Giovanni XXIII HospitalNot yet recruiting
-
BayerCompletedMultiple SclerosisBelgium, Italy, Spain, France, Switzerland, Israel, Czech Republic, Canada, Austria, Poland, Germany, Netherlands, United Kingdom, Hungary, Portugal, Finland, Norway, Sweden, Slovenia, Denmark
-
University Hospital, BonnRecruitingLiver CirrhosesGermany
-
Yale UniversityUniversity of Illinois at Urbana-ChampaignRecruitingDiabetes Mellitus | Peripheral Arterial DiseaseUnited States
-
Mauna Kea TechnologiesEmissary International LLC; Cellvizio Inc.CompletedAdenocarcinoma | Barrett's Esophagus | Barrett Esophagus | Barrett Syndrome | Barrett's SyndromeUnited States, France, Germany
-
BayerTerminatedAnterior Ischemic Optic NeuropathyUnited States, Australia, Canada